{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T08:56:58Z","timestamp":1793350618740,"version":"4.5.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T00:00:00Z","timestamp":1782345600000},"content-version":"am","delay-in-days":297,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01EY033233"],"award-info":[{"award-number":["R01EY033233"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Diabetes and its Complications"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.jdiacomp.2025.109091","type":"journal-article","created":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T19:18:16Z","timestamp":1748287096000},"page":"109091","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["High rate of complications in a real-world cohort of youth with T2D: a multicenter analysis"],"prefix":"10.1016","volume":"39","author":[{"given":"Dhruva","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy S.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bliss","family":"Magella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mozhdeh","family":"Bahrainian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.Y. Alvin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veeral","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roomasa","family":"Channa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7674-520X","authenticated-orcid":false,"given":"Risa M.","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdiacomp.2025.109091_bb0005","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jpeds.2022.08.010","article-title":"The coronavirus disease 2019 pandemic is associated with a substantial rise in frequency and severity of presentation of youth-onset type 2 diabetes","volume":"251","author":"Magge","year":"2022","journal-title":"J Pediatr"},{"key":"10.1016\/j.jdiacomp.2025.109091_bb0010","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/S2213-8587(23)00025-6","article-title":"Trends in incidence of youth-onset type 1 and type 2 diabetes in the USA, 2002\u201318: results from the population-based SEARCH for Diabetes in Youth study","volume":"11","author":"Wagenknecht","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jdiacomp.2025.109091_bb0015","doi-asserted-by":"crossref","first-page":"313","DOI":"10.2337\/dc22-0945","article-title":"Projections of Type 1 and Type 2 diabetes burden in the U.S. population aged <20 years through 2060: the SEARCH for diabetes in youth study","volume":"46","author":"Tonnies","year":"2023","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2025.109091_bb0020","doi-asserted-by":"crossref","first-page":"780","DOI":"10.2337\/dc13-1879","article-title":"Design of studies of \u03b2-cell preservation in prediabetes and early type 2 diabetes across the life span","volume":"37","author":"Consortium Restoring Insulin Secretion (RISE)","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2025.109091_bb0025","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.2337\/dc18-0243","article-title":"Metabolic contrasts between youth and adults with impaired glucose tolerance or recently diagnosed type 2 diabetes: II. observations using the oral glucose tolerance test","volume":"41","author":"Consortium","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2025.109091_bb0030","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1056\/NEJMoa1109333","article-title":"A clinical trial to maintain glycemic control in youth with type 2 diabetes","volume":"366","author":"Group","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jdiacomp.2025.109091_bb0035","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1056\/NEJMoa2100165","article-title":"Long-term complications in youth-onset type 2 diabetes","volume":"385","year":"2021","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.jdiacomp.2025.109091_bb0040","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.2337\/dc22-2503","article-title":"Prevalence, progression, and modifiable risk factors for diabetic retinopathy in youth and young adults with youth-onset type 1 and type 2 diabetes: the SEARCH for diabetes in youth study","volume":"46","author":"Jensen","year":"2023","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2025.109091_bb0045","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1056\/NEJMoa0806470","article-title":"10-year follow-up of intensive glucose control in type 2 diabetes","volume":"359","author":"Holman","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jdiacomp.2025.109091_bb0050","doi-asserted-by":"crossref","first-page":"136","DOI":"10.7326\/0003-4819-124-1_Part_2-199601011-00011","article-title":"United Kingdom Prospective Diabetes Study 17: a 9-year update of a randomized, controlled trial on the effect of improved metabolic control on complications in non-insulin-dependent diabetes mellitus","volume":"124","author":"Turner","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jdiacomp.2025.109091_bb0055","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.2337\/dc17-0179","article-title":"Prevalence of and risk factors for diabetic peripheral neuropathy in youth with type 1 and type 2 diabetes: SEARCH for diabetes in youth study","volume":"40","author":"Jaiswal","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2025.109091_bb0060","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.2337\/dc14-0574","article-title":"The SEARCH for Diabetes in Youth study: rationale, findings, and future directions","volume":"37","author":"Hamman","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2025.109091_bb0065","doi-asserted-by":"crossref","first-page":"e2334953","DOI":"10.1001\/jamanetworkopen.2023.34953","article-title":"Incidence of diabetes among youth before and during the COVID-19 pandemic","volume":"6","author":"Mefford","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jdiacomp.2025.109091_bb0070","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1053\/j.gastro.2009.12.052","article-title":"SAFETY study: alanine aminotransferase cutoff values are set too high for reliable detection of pediatric chronic liver disease","volume":"138","author":"Schwimmer","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jdiacomp.2025.109091_bb0075","first-page":"1","article-title":"Construction of LMS parameters for the Centers for Disease Control and Prevention 2000 growth charts","volume":"63","author":"Flegal","year":"2013","journal-title":"Natl Health Stat Report"},{"key":"10.1016\/j.jdiacomp.2025.109091_bb0080","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1080\/03014460.2020.1808065","article-title":"A method for calculating BMI z-scores and percentiles above the 95(th) percentile of the CDC growth charts","volume":"47","author":"Wei","year":"2020","journal-title":"Ann Hum Biol"},{"key":"10.1016\/j.jdiacomp.2025.109091_bb0085","series-title":"Endotext","article-title":"Type 2 diabetes in children and adolescents - a focus on diagnosis and treatment","author":"Pinhas-Hamiel","year":"2000"},{"key":"10.1016\/j.jdiacomp.2025.109091_bb0090","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1007\/s00125-023-05903-w","article-title":"Racial difference in the association between non-alcoholic fatty liver disease and incident type 2 diabetes: findings from the CARDIA study","volume":"66","author":"Hatano","year":"2023","journal-title":"Diabetologia"},{"key":"10.1016\/j.jdiacomp.2025.109091_bb0095","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1001\/jamapediatrics.2022.2052","article-title":"Trends in obesity prevalence among children and adolescents aged 2 to 19 years in the US from 2011 to 2020","volume":"176","author":"Hu","year":"2022","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.jdiacomp.2025.109091_bb0100","first-page":"101356","article-title":"Body mass index in adolescence, risk of type 2 diabetes and associated complications: a nationwide cohort study of men","volume":"46","author":"Karin","year":"2022","journal-title":"EClinMed"},{"key":"10.1016\/j.jdiacomp.2025.109091_bb0105","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1007\/s00125-020-05362-7","article-title":"BMI and BMI change following incident type 2 diabetes and risk of microvascular and macrovascular complications: the EPIC-Potsdam study","volume":"64","author":"Polemiti","year":"2021","journal-title":"Diabetologia"},{"key":"10.1016\/j.jdiacomp.2025.109091_bb0110","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1111\/pedi.13234","article-title":"Use of glucagon-like peptide-1 receptor agonists for pediatric patients with obesity and diabetes: the providers\u2019 perspectives","volume":"22","author":"Gourgari","year":"2021","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/j.jdiacomp.2025.109091_bb0115","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1056\/NEJMoa1903822","article-title":"Liraglutide in children and adolescents with type 2 diabetes","volume":"381","author":"Tamborlane","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jdiacomp.2025.109091_bb0120","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1089\/dia.2013.0366","article-title":"Liraglutide\u2019s safety, tolerability, pharmacokinetics, and pharmacodynamics in pediatric type 2 diabetes: a randomized, double-blind, placebo-controlled trial","volume":"16","author":"Klein","year":"2014","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.jdiacomp.2025.109091_bb0125","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.2337\/dc21-2275","article-title":"Once-weekly exenatide in youth with type 2 diabetes","volume":"45","author":"Tamborlane","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2025.109091_bb0130","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1056\/NEJMoa2204601","article-title":"Once-weekly dulaglutide for the treatment of youths with type 2 diabetes","volume":"387","author":"Arslanian","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jdiacomp.2025.109091_bb0135","doi-asserted-by":"crossref","first-page":"6295345","DOI":"10.1155\/2024\/6295345","article-title":"Efficacy and safety of SGLT2 inhibitors in pediatric patients and young adults: A systematic review and meta-analysis of randomized controlled trials","volume":"2024","author":"dos Santos Borges","year":"2024","journal-title":"Pediatr Diabetes"},{"issue":"4","key":"10.1016\/j.jdiacomp.2025.109091_bb0140","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1111\/dom.15430","article-title":"Real-world use of GLP-1 receptor agonists in youth with type 2 diabetes is associated with short-term improvements in hemoglobin A1c","volume":"26","author":"Samuels","year":"2024","journal-title":"Diabetes Obesity and Metabolism"},{"key":"10.1016\/j.jdiacomp.2025.109091_bb0145","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S2213-8587(21)00203-5","article-title":"Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials","volume":"9","author":"Sattar","year":"2021","journal-title":"Lancet Diabetes Endocrinol"}],"container-title":["Journal of Diabetes and its Complications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872725001448?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872725001448?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T17:05:57Z","timestamp":1762362357000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1056872725001448"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":29,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S1056872725001448"],"URL":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2025.109091","relation":{},"ISSN":["1056-8727"],"issn-type":[{"value":"1056-8727","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High rate of complications in a real-world cohort of youth with T2D: a multicenter analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Diabetes and its Complications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2025.109091","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109091"}}